Safety and Efficacy Evaluation of IM19 CAR-T Cells
Clinical trial NCT03142646 · UNKNOWN
Trial details
- NCT number
- NCT03142646
- Sponsor
- Beijing Immunochina Medical Science & Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-30
- Primary completion
- 2018-06-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.